Lenalidomide Plus Dexamethasone (Rev/Dex) in Newly Diagnosed Myeloma: Response to Therapy, Time to Progression, and Survival.
Year: 2006
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Mayo Clinic, Mayo Clinic in Arizona
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2592512558
